These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 6795287

  • 1. The multimeric distribution of factor VIII-related antigen studied by an improved crossed-immunoelectrophoresis technique.
    Lamb MA, Reisner HM, Cooper HA, Wagner RH.
    J Lab Clin Med; 1981 Nov; 98(5):751-63. PubMed ID: 6795287
    [Abstract] [Full Text] [Related]

  • 2. Multimers of von Willebrand antigen in therapeutic factor VIII concentrates.
    Vukovich TC.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Nov; 113(6):831-40. PubMed ID: 2436998
    [Abstract] [Full Text] [Related]

  • 3. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
    Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H.
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885
    [Abstract] [Full Text] [Related]

  • 4. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A, Berneman Z, Schroyens W, Michiels JJ.
    Acta Haematol; 2009 Oct; 121(2-3):128-38. PubMed ID: 19506359
    [Abstract] [Full Text] [Related]

  • 5. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J, Peake I, Bloom A.
    Thromb Haemost; 1983 Aug 30; 50(2):509-12. PubMed ID: 6415844
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Qualitative VIIIR: AG function screening of multiple samples by two-dimensional crossed immunoelectrophoretic technique.
    Enayat MS, Hill FG.
    Med Lab Sci; 1982 Oct 30; 39(4):357-62. PubMed ID: 6817018
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, van de Velde A, van Vliet H.
    Semin Thromb Hemost; 2005 Nov 30; 31(5):577-601. PubMed ID: 16276467
    [Abstract] [Full Text] [Related]

  • 14. Characterization of factor VIII related protein synthesized by human endothelial cell: a study of structure and function.
    Chan V, Chan TK.
    Thromb Haemost; 1982 Oct 29; 48(2):177-81. PubMed ID: 6817445
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Variant von Willebrand's disease. A study emphasizing crossed-immunoelectrophoresis.
    Green D, Philip KJ.
    Thromb Haemost; 1980 Feb 29; 43(1):2-5. PubMed ID: 6967636
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.